- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Therapeutic Options Under Investigation
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-13
DOI
10.3389/fphar.2020.01196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
- (2020) Sundy N.Y. Yang et al. ANTIVIRAL RESEARCH
- Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department
- (2020) J. Tao et al. BRITISH JOURNAL OF DERMATOLOGY
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
- (2020) Abdo A. Elfiky LIFE SCIENCES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Coronavirus puts drug repurposing on the fast track
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak
- (2020) Liangjun Chen et al. Emerging Microbes & Infections
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China
- (2020) Lei Pan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treatment of COVID-19 Patients with Convalescent Plasma
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells
- (2020) Yueping Liu et al. CLINICAL INFECTIOUS DISEASES
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
- (2020) Andrea Giacomelli et al. CLINICAL INFECTIOUS DISEASES
- Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
- (2020) Tao Zhang et al. CURRENT BIOLOGY
- Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
- (2020) Dan Yan et al. EUROPEAN RESPIRATORY JOURNAL
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- A Review of Coronavirus Disease-2019 (COVID-19)
- (2020) Tanu Singhal INDIAN JOURNAL OF PEDIATRICS
- Novel coronavirus: From discovery to clinical diagnostics
- (2020) Tung Phan INFECTION GENETICS AND EVOLUTION
- Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
- (2020) Lisheng Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Teicoplanin: an alternative drug for the treatment of COVID-19?
- (2020) Sophie Alexandra Baron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
- (2020) Qiang Ding et al. JOURNAL OF MEDICAL VIROLOGY
- Cutaneous manifestations in COVID‐19: a first perspective
- (2020) S. Recalcati JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Developing antibody tests for SARS-CoV-2
- (2020) Anna Petherick LANCET
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Drug researchers pursue new lines of attack against COVID-19
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
- (2020) Zhenwei Wang et al. BioScience Trends
- COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
- (2020) Kuldeep Dhama et al. Human Vaccines & Immunotherapeutics
- In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
- (2020) Chang Kyung Kang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
- (2020) Xi Wang et al. Cell Discovery
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
- (2020) Erin K McCreary et al. Open Forum Infectious Diseases
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
- (2020) Chunguang Yang et al. Frontiers in Public Health
- Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission—A Preliminary Report of a Retrospective Cohort Study
- (2020) Jin-nong Zhang et al. Current Medical Science
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
- (2020) Tobias Janowitz et al. GUT
- Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
- (2020) Samia Arshad et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early safety indicators of COVID-19 convalescent plasma in 5000 patients
- (2020) Michael J. Joyner et al. JOURNAL OF CLINICAL INVESTIGATION
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
- (2020) Julien Andreani et al. MICROBIAL PATHOGENESIS
- Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats
- (2020) Qishan Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The effect of large-scale anti-contagion policies on the COVID-19 pandemic
- (2020) Solomon Hsiang et al. NATURE
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
- (2020) Colin D. Funk et al. Frontiers in Pharmacology
- Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
- (2020) Christian Foerch et al. Multiple Sclerosis and Related Disorders
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial
- (2020) Oriol Mitjà et al. CLINICAL INFECTIOUS DISEASES
- Influenza virus polymerase inhibitors in clinical development
- (2019) Frederick G. Hayden et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge
- (2019) Michael K. Lo et al. Science Translational Medicine
- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- The Role of Interleukin 6 During Viral Infections
- (2019) Lauro Velazquez-Salinas et al. Frontiers in Microbiology
- Inhibitors of nuclear transport
- (2019) David A Jans et al. CURRENT OPINION IN CELL BIOLOGY
- Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process
- (2019) Dat Huu Tran et al. JOURNAL OF ANTIBIOTICS
- The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication
- (2019) Morgan R. Herod et al. JOURNAL OF GENERAL VIROLOGY
- Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses
- (2019) Chunfeng Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus
- (2019) Shengnan Zhang et al. ANTIVIRAL RESEARCH
- The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection
- (2019) George R. Painter et al. ANTIVIRAL RESEARCH
- Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
- (2019) Maria L. Agostini et al. JOURNAL OF VIROLOGY
- Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
- (2019) Mart Toots et al. Science Translational Medicine
- Fingolimod retains cytolytic T cells and limits T follicular helper cell infection in lymphoid sites of SIV persistence
- (2019) Maria Pino et al. PLoS Pathogens
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
- (2018) Jeong-Joong Yoon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
- (2018) Jae-Hoon Ko et al. ANTIVIRAL THERAPY
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)
- (2018) G. Redelman-Sidi et al. CLINICAL MICROBIOLOGY AND INFECTION
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
- (2018) Jan Haviernik et al. Viruses-Basel
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques
- (2018) Jérémie Guedj et al. PLOS MEDICINE
- Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
- (2018) Hideki Tani et al. PLoS One
- Two regimens of dexamethasone versus prednisolone for acute exacerbations in asthmatic Egyptian children
- (2018) Dalia A Elkharwili et al. European Journal of Hospital Pharmacy-Science and Practice
- Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure
- (2017) Alexey V. Shvetsov et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Fingolimod induces neuronal-specific gene expression with potential neuroprotective outcomes in maturing neuronal progenitor cells exposed to HIV
- (2017) Rebeca Geffin et al. JOURNAL OF NEUROVIROLOGY
- β-D- N 4 -Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
- (2017) Nadya Urakova et al. JOURNAL OF VIROLOGY
- Trial of Tocilizumab in Giant-Cell Arteritis
- (2017) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- PharmGKB summary
- (2017) Alison E. Fohner et al. Pharmacogenetics and Genomics
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus
- (2017) Jenniffer Angulo et al. PLoS Neglected Tropical Diseases
- Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort
- (2017) Alessia Manni et al. Brain and Behavior
- Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
- (2017) Chunfeng Li et al. EBioMedicine
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses
- (2017) Michael K. Lo et al. Scientific Reports
- Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
- (2017) Sergey A. Shiryaev et al. Scientific Reports
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Teicoplanin inhibits Ebola pseudovirus infection in cell culture
- (2016) Yizhuo Wang et al. ANTIVIRAL RESEARCH
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
- (2016) Eve-Isabelle Pécheur et al. JOURNAL OF VIROLOGY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Zika Virus in the Americas — Yet Another Arbovirus Threat
- (2016) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
- (2016) Rodrigo Delvecchio et al. Viruses-Basel
- Human coronavirus and severe acute respiratory infection in Southern Brazil
- (2016) Hygor Trombetta et al. Pathogens and Global Health
- Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
- (2016) Jean-François Rossignol Journal of Infection and Public Health
- Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
- (2016) Veronika Götz et al. Scientific Reports
- Sphingosine-1-Phosphate Receptor Antagonism Enhances Proliferation and Migration of Engrafted Neural Progenitor Cells in a Model of Viral-Induced Demyelination
- (2015) Caroline A. Blanc et al. AMERICAN JOURNAL OF PATHOLOGY
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
- (2015) Jianzhong Cao et al. ANTIVIRAL RESEARCH
- Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
- (2015) M. A. A. Al-Bari JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
- (2015) Kentaro Yamada et al. JOURNAL OF INFECTIOUS DISEASES
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF INFECTIOUS DISEASES
- Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
- (2015) Li-Fong Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis
- (2015) N. Pfender et al. NEUROLOGY
- The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells
- (2015) Mutsuo Yamaya et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Antiviral Activity of Chloroquine Against Dengue Virus Type 2 Replication inAotusMonkeys
- (2015) Kleber Juvenal Silva Farias et al. VIRAL IMMUNOLOGY
- Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
- (2015) Olivier Reynard et al. Viruses-Basel
- Changing the face of hepatitis C management – the design and development of sofosbuvir
- (2015) Andrew Delemos et al. Drug Design Development and Therapy
- Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses
- (2015) Wahyu N. Wulan et al. Frontiers in Microbiology
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nitazoxanide: A first-in-class broad-spectrum antiviral agent
- (2014) Jean-François Rossignol ANTIVIRAL RESEARCH
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: Synthesis and antiviral studies
- (2014) Ilona Bereczki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mechanism of Action of Colchicine in the Treatment of Gout
- (2014) Nicola Dalbeth et al. CLINICAL THERAPEUTICS
- Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
- (2014) Aline Schögler et al. EUROPEAN RESPIRATORY JOURNAL
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Identification of Diverse Alphacoronaviruses and Genomic Characterization of a Novel Severe Acute Respiratory Syndrome-Like Coronavirus from Bats in China
- (2014) B. He et al. JOURNAL OF VIROLOGY
- Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model
- (2014) Zixue Shi et al. Virology Journal
- Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
- (2014) Takashi Nagata et al. Disaster Medicine and Public Health Preparedness
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
- (2013) M.Y.F. Tay et al. ANTIVIRAL RESEARCH
- Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication
- (2013) Lindsay Lundberg et al. ANTIVIRAL RESEARCH
- Thiazolides, a New Class of Antiviral Agents Effective against Rotavirus Infection, Target Viral Morphogenesis, Inhibiting Viroplasm Formation
- (2013) S. La Frazia et al. JOURNAL OF VIROLOGY
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
- (2013) S. Gierer et al. JOURNAL OF VIROLOGY
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Chloroquine Inhibits Dengue Virus Type 2 Replication in Vero Cells but Not in C6/36 Cells
- (2013) Kleber Juvenal Silva Farias et al. TheScientificWorldJOURNAL
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
- (2013) Darryl Falzarano et al. Scientific Reports
- Nuclear trafficking of proteins from RNA viruses: Potential target for antivirals?
- (2012) Leon Caly et al. ANTIVIRAL RESEARCH
- Novel nucleoside analogue FNC is effective against both wild-type and lamivudine-resistant hepatitis B virus clinical isolates
- (2012) Yubing Zhou et al. ANTIVIRAL THERAPY
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
- (2012) Kylie M. Wagstaff et al. BIOCHEMICAL JOURNAL
- Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy
- (2012) Nicholas I. Paton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Teicoplanin therapy leading to a significant decrease in viral load in a patient with chronic hepatitis C
- (2012) A. Maieron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
- (2012) E. Mastrangelo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Japanese Encephalitis Virus Enters Rat Neuroblastoma Cells via a pH-Dependent, Dynamin and Caveola-Mediated Endocytosis Pathway
- (2012) Y.-Z. Zhu et al. JOURNAL OF VIROLOGY
- Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
- (2012) P. C. Y. Woo et al. JOURNAL OF VIROLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
- (2012) Tine De Burghgraeve et al. PLoS One
- Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience
- (2011) James R. Smith et al. ADVANCES IN THERAPY
- FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cells
- (2011) Qiang Wang et al. BIOCHEMICAL PHARMACOLOGY
- Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics
- (2011) S. Obeid et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
- (2011) Raymund R. Razonable MAYO CLINIC PROCEEDINGS
- Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study
- (2011) G. Carraro et al. VACCINE
- Azithromycin induces anti-viral responses in bronchial epithelial cells
- (2010) V. Gielen et al. EUROPEAN RESPIRATORY JOURNAL
- Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma
- (2010) Michele Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
- (2010) Vianney Tricou et al. PLoS Neglected Tropical Diseases
- Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
- (2009) E. Keyaerts et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis
- (2009) S. Svetitsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
- (2009) S. Belouzard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
- (2008) Aránzazu González Canga et al. AAPS Journal
- Use of Corticosteroids in Treating Infectious Diseases
- (2008) Steven McGee ARCHIVES OF INTERNAL MEDICINE
- SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
- (2008) Hongliang Wang et al. CELL RESEARCH
- Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances
- (2008) W. G. Nichols et al. CLINICAL MICROBIOLOGY REVIEWS
- Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
- (2008) Erik De Clercq INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles
- (2008) Y. L. Siu et al. JOURNAL OF VIROLOGY
- Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK
- (2007) Masakazu Kono et al. ANTIVIRAL RESEARCH
- Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
- (2007) Brent E. Korba et al. ANTIVIRAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search